symptom-guides

Published by Floriva · Updated 2026-04-28 · How Floriva checks its guides

Bleeding Between Periods: What Causes It and How to Track It

Intermenstrual bleeding has distinct causes by timing and appearance. Learn to identify the pattern and when to seek clinical evaluation.

Bleeding between periods, called intermenstrual bleeding, is not a diagnosis but a symptom that points toward a cause. Mid-cycle spotting is often ovulation-related and benign; bleeding earlier or later in the cycle, or heavier than spotting, points toward hormonal disruption, structural causes like polyps or fibroids, infection, or in some cases pathology that warrants clinical evaluation. The timing, amount, and pattern are the key data points.

Intermenstrual Bleeding Is a Symptom, Not a Diagnosis

Bleeding that appears between periods means something. The question is what. The timing within the cycle, the character of the bleeding, whether it recurs, and what other symptoms accompany it together point toward the cause. Getting to a useful answer requires knowing those details, which is exactly what cycle tracking provides.

This guide works through the major causes, starting with the most common and moving toward those that need clinical attention sooner.

This guide is for educational purposes only and is not a substitute for medical advice.

Mid-Cycle Spotting: Ovulation

For people who experience it, ovulation spotting appears around day 10 to 16 of the cycle (counting from the first day of the last period). It is:

• Light: traces to a pantyliner amount

• Pink or light red (sometimes brownish if blood takes time to travel)

• Brief: lasting one to two days

• Possibly accompanied by one-sided pelvic pain (mittelschmerz) or a change in cervical mucus to clear and stretchy

This happens because of a brief estrogen dip just before the LH surge triggers ovulation, or because the follicle's physical rupture causes minor local bleeding. Both are normal and do not require treatment.

If mid-cycle spotting appears consistently at the same point each cycle and matches this description, ovulation is the probable cause. Tracking will confirm it.

Hormonal Contraceptive Breakthrough Bleeding

Breakthrough bleeding is the most common cause of unexpected bleeding in people using hormonal contraception. It reflects the endometrium adjusting to an altered hormonal environment.

It is particularly common:

• In the first three to four months of starting a new method

• With progestin-only pills ("mini-pill"), particularly if pills are taken at irregular times

• With hormonal IUDs in the first three to six months after insertion

• When combined pill packs are run together (skipping the placebo week)

• With low-dose contraceptive formulations that provide less endometrial stabilization

Breakthrough bleeding that resolves within three to four months of starting a contraceptive does not require intervention. Persistent breakthrough bleeding beyond that window, or bleeding that is heavier than spotting, warrants reassessment of the contraceptive method.

Uterine Polyps

Uterine polyps are the structural cause most likely to produce recurrent intermenstrual bleeding that is not explained by contraceptive effects or obvious cycle-phase timing. They are benign endometrial growths, typically small, that can bleed irregularly because they are vascularized, fragile, and project into the uterine cavity where they receive pressure from uterine wall contractions.

Polyp-associated bleeding tends to:

• Recur consistently across multiple cycles

• Occur at varying points in the cycle (not clearly mid-cycle or pre-period)

• Be light but persistent

• Not resolve on its own

Transvaginal ultrasound identifies most polyps. A saline-infused sonogram (SIS) or hysteroscopy provides clearer detail if needed. Removal is outpatient and straightforward.

Uterine Fibroids

Fibroids in the uterine wall are very common and most are asymptomatic. The subset most likely to cause intermenstrual bleeding are submucosal fibroids, those that project into the uterine cavity and disrupt the endometrial lining.

Fibroid-related bleeding is more likely to be heavier than spotting, may make periods heavier overall, and can be accompanied by pelvic pressure or a sensation of fullness. Fibroids do not always require treatment, but they benefit from monitoring and clinical evaluation to determine the right management approach.

Anovulatory Cycles and Hormonal Disruption

When ovulation does not occur, the cycle continues under estrogen influence without progesterone. The endometrium thickens but is not properly stabilized. Eventually it sheds irregularly, producing unpredictable bleeding that does not fit the expected period timing.

Anovulatory cycles are more common during:

• Periods of significant stress

• Rapid weight changes or low body fat

• Intensive exercise training

• Thyroid dysfunction (both hypo- and hyperthyroidism)

• PCOS (polycystic ovary syndrome), which involves disrupted ovulation

• Perimenopause

The bleeding produced by anovulatory cycles can appear at almost any cycle point, may be lighter or heavier than a typical period, and may recur irregularly. If you are experiencing irregular bleeding alongside other symptoms of thyroid dysfunction (temperature sensitivity, energy changes, hair loss, weight changes) or PCOS (irregular cycles, acne, excess body hair), hormonal evaluation is worth pursuing.

Infection and Cervicitis

STIs including chlamydia, gonorrhea, and trichomoniasis can cause cervical inflammation that produces intermenstrual bleeding, particularly after sex. This type of bleeding tends to be associated with:

• New sexual partners

• Absence of other clear cycle-related explanation

• Possible concurrent changes in discharge

• Cervical tenderness if examined

STI testing is part of the standard clinical evaluation for intermenstrual bleeding in sexually active people.

Endometrial Hyperplasia and Cancer: The Reason to Get Evaluated

Endometrial hyperplasia (abnormal thickening of the uterine lining) and uterine cancer can both present with intermenstrual bleeding. These are less common causes, particularly in younger people, but they are the ones that give intermenstrual bleeding clinical urgency.

Risk factors for endometrial hyperplasia include:

• Obesity (adipose tissue produces estrogen, creating unopposed estrogen)

• Anovulatory cycles (same mechanism: estrogen without progesterone)

• PCOS

• Estrogen therapy without progesterone

• Age (most uterine cancer occurs post-menopause, but can occur earlier)

Recurring intermenstrual bleeding, particularly in someone with risk factors, requires evaluation. Ultrasound can assess endometrial thickness. Endometrial biopsy can rule out hyperplasia and cancer. Getting evaluated is not an overreaction.

What to Track and How

For any episode of intermenstrual bleeding:

• Date and cycle day

• Amount: spotting / light / moderate / heavy

• Color: pink, bright red, brown

• Duration: how many days

• Relation to period: how many days after last period ended, or before next period due

• Possible context: recent sex, recent pelvic exam, recent contraceptive change

• Associated symptoms: pain, discharge changes, fever

Three cycles of this logged data gives a clinician a pattern to work with rather than a single event to interpret in isolation.

The Privacy Case for On-Device Tracking

Intermenstrual bleeding records, combined with sexual activity logs, cycle dates, and symptom notes, create a detailed reproductive health profile. This data is sensitive from a legal standpoint. In states with abortion restrictions, law enforcement has sought period tracker data in criminal investigations. Period tracking app data is not protected by HIPAA.

Flo Health's FTC enforcement action and $59.5 million class action settlement confirmed that major period apps shared health data with third parties. An on-device tracker does not transmit data to any server. There is no company database to subpoena, sell to data brokers, or expose in a breach. For a symptom pattern with reproductive health implications, the storage location of your data is a meaningful decision.